Medical Devices Acquisitions in Colorado

Vance Street Capital has acquired Injectech from The West Group and added it to its newly formed VSC Medical Molding platform, expanding the platform's precision injection-molding and single-use fluid management capabilities for medical device, life science and bioprocessing customers. Injectech, headquartered in Fort Collins, Colorado, will operate alongside Resenex under the VSC Medical Molding platform to broaden component offerings and custom manufacturing capabilities.

An affiliate of H.I.G. Capital has completed the acquisition of the Spine division of ZimVie, Inc. The acquired business will operate independently under the new name Highridge Medical, headquartered in Westminster, Colorado, and H.I.G. plans to invest in R&D, product innovation and strategic growth to build a leading privately held spine platform.

WillowWood Global, a Mount Sterling, Ohio prosthetics manufacturer and distributor, has acquired Denver-based Xtremity, the developer of the XtremityTT thermoformable, adjustable prosthetic socket. The acquisition adds a patented, carbon-reinforced polymer socket preform to WillowWood's portfolio to speed fabrication, improve clinician adjustability, and expand its custom socket capabilities.

Sunrise Medical has completed the strategic acquisition of Ride Designs, a Denver-based maker of premium custom wheelchair seating systems. The deal expands Sunrise Medical’s seating and positioning portfolio, bringing Ride Designs’ clinical expertise, Aspen Seating Clinic services and advanced 3D printing capabilities into Sunrise’s global mobility platform.

Ocutrx Technologies has acquired Spectrum Advanced Manufacturing Technologies, a Colorado Springs-based high-reliability electronics and assembly firm, to bring medical-device and hi-rel manufacturing capabilities in-house and repatriate supply chain operations to the U.S. Spectrum's founder Jeff Riggs will remain as a minority partner and CEO during integration, and Ocutrx plans to leverage Spectrum's process lines and ISO optics lab to scale AR/XR medical headsets and other devices in compliance with FDA and global standards.

Mars, Incorporated agreed to acquire Heska Corporation for $120.00 per share (approximately $1.3 billion equity value), bringing the veterinary diagnostics company into Mars Petcare's Science & Diagnostics business. The acquisition is intended to broaden Mars' point-of-care diagnostic offerings, accelerate R&D and innovation, and expand access to veterinary diagnostics for companion animal health globally.

Applied UV, Inc. (NASDAQ:AUVI) entered into definitive agreements to acquire PURO Lighting, LLC and LED Supply Co. in a combined transaction valued at approximately $20 million (cash and restricted shares). The deals would roughly double Applied UV's size—adding an estimated $18 million of revenue—and expand its distribution, sales capabilities and access to PURO's strategic relationships (including Acuity Brands) for FDA‑cleared disinfection products.

ATL Technology has acquired BioVision Technologies, LLC, a developer of disposable scopes and micro-endoscopic imaging solutions. ATL will integrate BioVision’s endoscopy and disposable-scope capabilities into its medical imaging and access business unit to expand single-use minimally invasive device offerings; BioVision’s founder will remain with ATL as an Imaging Innovation and Development Fellow.

Innovia Medical has acquired Apdyne Medical Company, gaining ownership of the Apdyne Phenol Applicator Kit used to anesthetize the tympanic membrane during in-office myringotomy procedures. The deal expands Innovia’s ENT product portfolio and brings manufacturing and distribution of the single-use phenol applicator kit in-house.

SeaStar Medical, a developer of an extracorporeal Selective Cytopheretic Device (SCD) for treating acute kidney injury and hyperinflammation, is merging with Nasdaq-listed SPAC LMF Acquisition Opportunities, Inc. The merger (an ~$85 million SPAC transaction advised by Skyway) is intended to provide SeaStar access to capital markets to accelerate clinical development, FDA filings, and commercialization.

Solmetex, LLC, a portfolio company of Avista Capital Partners, has acquired Sterisil, a Palmer Lake, Colorado-based developer of dental unit waterline infection control products. The add-on strengthens Solmetex's position as a category leader in dental water treatment and safety management, expanding product capabilities and support for dental practices and DSOs in the U.S. and internationally.

GenNx360 Capital Partners has made a majority investment in Tensentric, a Boulder-based provider of design, engineering, prototyping and assembly services for medical technology, IVD and life-sciences companies. The investment will support Tensentric's next phase of growth and enable the company to scale its services capabilities through organic and inorganic initiatives.

TriMas (NASDAQ: TRS) has acquired Intertech Plastics, a Denver-based custom injection molder that supplies precision plastic components for medical, consumer and industrial applications. The acquisition brings Intertech's ISO 13485-certified, Class 8 cleanroom medical manufacturing capabilities into TriMas Packaging and expands TriMas' product offerings into the life sciences/medical end market.

Zynex, Inc. acquired 100% of Kestrel Labs, Inc. in a transaction that closed December 22, 2021 for approximately $31.0 million (about $16.0 million cash financed by Bank of America and $15.0 million in Zynex common stock). Kestrel Labs develops laser-based, noninvasive patient monitoring devices (NiCO CO‑Oximeter and HemeOx) that are not yet FDA-cleared; Zynex said it will integrate the technologies into its monitoring portfolio and pursue regulatory clearance and commercialization.

Hologic, Inc. agreed to acquire Bolder Surgical, a Colorado-based developer of advanced energy vessel sealing and dissection devices, for approximately $160 million and has completed the previously announced transaction. The acquisition adds laparoscopic vessel sealing, dividing and dissecting devices (including pediatric-focused 3 mm and 5 mm tools) to Hologic’s Surgical portfolio, enabling capability expansion and broader commercialization into OB/GYN and hospital markets; Bolder was expected to generate about $10 million of product revenue in the calendar year.

SteriPack Group has acquired Frederick, Colorado-based Halleck‑Willard, Inc. (HWI) to expand its medical device design and engineering capabilities. HWI — a turnkey R&D and engineering firm specializing in electronics, firmware, embedded software, IoT, RF and microminiature design for medical and other industries — will become SteriPack's electronics and software design center, augmenting SteriPack's product lifecycle services from concept through regulatory navigation and manufacturing.